Stem cell therapy produces marked positive effect in treatment of arterial hypertension (elevated blood pressure). In particular, at UNIQUE CELL TREATMENT CLINIC patients with primary arterial hypertension of grades I-III with frequent arterial crises, with or without complications, undergo transplantation of fetal stem cells of ectodermal and mesenchymal origin.

Before the transplantation, optimal hypotensive therapy regimen is selected, which combined with fetal stem cells brings the most lasting and steady effect. Then our specialists constantly monitor the patient’s condition after the treatment, correct the dose of drugs downwards which makes the patient’s life longer and better quality.

In 3–5 months after fetal stem cell treatment, all patients note stable decline in blood pressure and reduction of hypotensive therapy by approximately 50%. Over time, 85% of patients lose the need for hypotensive therapy.